Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke.
about
Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcomePlatelet-activating factor enhancement of calcium influx and interleukin-6 expression, but not production, in human microglia.Cytokines: their role in stroke and potential use as biomarkers and therapeutic targetsStudies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to dateDistinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a ChipAnti-Inflammatory Effects of Traditional Chinese Medicines against Ischemic Injury in In Vivo Models of Cerebral IschemiaInflammation and infection in clinical strokeAG490 prevents cell death after exposure of rat astrocytes to hydrogen peroxide or proinflammatory cytokines: involvement of the Jak2/STAT pathwayClinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production.Vulnerability to stroke: implications of perinatal programming of the hypothalamic-pituitary-adrenal axisTranscriptional activation of endothelial cells by TGFβ coincides with acute microvascular plasticity following focal spinal cord ischaemia/reperfusion injury.Neuroprotection in acute ischaemic stroke. II: Clinical potential.Lack of macrophage migration inhibitory factor in mice does not affect hallmarks of the inflammatory/immune response during the first week after stroke.Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis.Potential of anticytokine therapies in central nervous system ischaemia.Middle cerebral artery occlusion model in rodents: methods and potential pitfalls.The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment.Neopterin levels in patients with cerebrovascular disease.Minocycline mitigates the gliogenic effects of proinflammatory cytokines on neural stem cells.The neuropathology and pathogenesis of systemic lupus erythematosus.Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volumeProof of concept: pharmacological preconditioning with a Toll-like receptor agonist protects against cerebrovascular injury in a primate model of stroke.The inflammatory response in cerebral ischemia: focus on cytokines in stroke patients.Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretionInflammatory markers and neuropsychological functioning: the Framingham Heart StudyReduced inflammatory phenotype in microglia derived from neonatal rat spinal cord versus brainCanine model of ischemic stroke with permanent middle cerebral artery occlusion: clinical features, magnetic resonance imaging, histopathology, and immunohistochemistryAmeliorative effects of Gualou Guizhi decoction on inflammation in focal cerebral ischemic-reperfusion injury.Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.Synthetic Oligodeoxynucleotides Containing Multiple Telemeric TTAGGG Motifs Suppress Inflammasome Activity in Macrophages Subjected to Oxygen and Glucose Deprivation and Reduce Ischemic Brain Injury in Stroke-Prone Spontaneously Hypertensive Rats.Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain.Interleukin-1 and neuronal injury.Interleukin-6 is increased in plasma and cerebrospinal fluid of community-dwelling domestic dogs with acute ischaemic stroke.Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke.The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines.Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.Applicability of biomarkers in ischemic stroke.The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.Role of brain inflammation in epileptogenesis.A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.
P2860
Q24794415-198C3BA2-A53A-49C8-A4FD-4A96C49F4C93Q24802345-AE068BB3-9231-4AA0-935F-4811E7680B99Q26998414-E40B456E-725C-4261-AD51-A266BCBEFEDDQ27001147-BD031BED-4AA8-4B78-B9C8-F76ABD3C99F9Q27319805-85CE9EE7-6510-4757-B5C0-0A75D4825B04Q28077229-AE697956-0EC3-4A19-A08D-370C9172E905Q28194382-56082224-C4B7-4E9E-869D-559DADE25BACQ28576489-8F9B7E73-B63F-41A6-8FA4-8687A874BA9AQ33276036-77BDFBB6-8AEA-4B18-8642-8D49200F0FA5Q33575275-2141B55A-202A-4CEF-B9BB-3F2D2631E26CQ33608063-1157E39D-7B1E-4331-9B40-BA8263CC636EQ33747433-55A02DEF-1BF3-4499-914B-B0CD94964ED5Q33945936-AF5D8F1E-7892-4030-A4DF-5E954E72F64EQ33996319-5ED91475-5D4F-4BF6-B614-376E7A88FAD6Q34452055-7ADAFB8B-0CB8-43B6-BF23-1CF56C8FF386Q34558344-5CF8CAE4-DFF8-40B0-A4DD-5A10031A872CQ34662653-3CE94CEF-4B17-414B-85F9-549D70C0F026Q34668014-32262F91-E5DB-4A4C-BBA2-5009F8069068Q34674246-9A44153A-347F-4915-8654-61F00290C000Q34680879-BF0B0FC9-C1D2-4024-B74E-8A6C7E089D98Q34729372-AA52BAF7-4759-4681-A016-E096A0E2BC78Q34997963-79564F55-F885-430B-A09B-F7F2FA6C0B14Q35008522-49C16E5E-FC6B-4684-824E-FF2860A7B1B5Q35097354-3787913A-D741-4FB0-8F28-907CEC3B0F79Q35123609-8E4B33E2-20B4-4C6B-871D-9092CDB9118FQ35184712-0ED71067-A37C-49DD-86C4-1E6A4082C2A6Q35199104-6363BFE1-4A72-4EB3-8ACD-486C196D6554Q35628458-A908BC3E-339E-4E5E-BE57-F6CF74C7BB47Q35789001-63196E43-A91E-4156-9D3A-918B0D3E5E98Q35810269-FCA45F55-3B55-4B7C-A892-C4A43B43DE2FQ35998206-6CE10F99-BF89-45E9-BE11-5A2ACB3B2064Q36202191-A7958499-5A74-43D2-8C11-851D5476C7ECQ36247166-8D980652-A80C-46D9-B2F0-18045BA3AD49Q36463740-FBEFDD6A-F1D2-4D04-9AE9-1658C047C4B3Q36559288-DCC43D0D-20BB-4538-80EB-F283F7CF2BFEQ36955326-48B6FB4C-748E-4B65-AAC0-FA4DBB07ED3EQ36986354-0D6B52B4-F0BA-4E95-9343-42A187852ACEQ37020840-1B37BA32-F2C6-4536-A293-4F5E23BEA151Q37040824-5E5EF6FD-7E9A-4027-8AB9-838F36E3C2EBQ37172697-771207C3-40F0-46FE-9C47-4CE288A342BB
P2860
Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Early intrathecal production o ...... ize of brain lesion in stroke.
@en
Early intrathecal production o ...... ize of brain lesion in stroke.
@nl
type
label
Early intrathecal production o ...... ize of brain lesion in stroke.
@en
Early intrathecal production o ...... ize of brain lesion in stroke.
@nl
prefLabel
Early intrathecal production o ...... ize of brain lesion in stroke.
@en
Early intrathecal production o ...... ize of brain lesion in stroke.
@nl
P2093
P356
P1433
P1476
Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke
@en
P2093
P304
P356
10.1161/01.STR.26.8.1393
P407
P577
1995-08-01T00:00:00Z